Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

École Polytechnique de Montréal

$33,000.00

Novel Thin Film Biomaterials for Tissue Engineering

FY 2016-17

Summary
Deposition of thin films and etching via the use of ""cold"" (thermodynamically non-equilibrium) low-pressure (LP) plasmas achieved prominence in information technology since the 1960s. Those two processes and a third, surface modification of polymers, are now also being used in many other industries. Recently, there has been much progress in implementing atmospheric-pressure (AP) cold plasmas, mostly the dielectric barrier discharge (DBD) variety, for those three process categories. Beside direct use of LP and AP plasmas, it is also possible to carry out such processes by vacuum-ultraviolet (VUV, lambda = 200 nm) photo-chemistry, since commercial (plasma-based) VUV sources can efficiently convert electrical energy into short-wavelength photons. A potential advantage of (mono-energetic) photo- chemistry over (LP- and AP-) plasma is that the former may result in more targeted reactions, with higher yields of the desired products. Research in the applicant's laboratory of all types (LP, AP, VUV) above has over the years resulted in well over 400 refereed publications, in two dozen patents, and in much technology transfer to industry. He proposes innovative research focused on novel AP plasma techniques and on thin organic films deposited on suitable substrates for use in bio-technological (e.g. tissue engineering) applications. Such coatings must be rich in certain types of chemical functionalities, for example in primary amines (-NH2), carboxylic (COOR), hydroxyl (-OH), or thiol (-SH) groups, they must adhere strongly to various substrate materials, must resist ""aging"" in atmosphere and dissolution in aqueous (cell-culture) media, among other criteria. Finally, of course, they must first and foremost elicit the desired bio-response from the cell-type(s) being cultured. This latter aspect calls for close collaboration with specialists in the cell-biological and medical sciences that are being addressed in any given sub-project. During the past decade, the applicant's laboratory has developed networks of collaborations, mostly with senior researchers in the medical faculty of McGill and Montreal universities. In the recent past NSERC specifically included ""Plasma Applications"" among areas of Interdisciplinary Materials Research that possess particularly high potential for socioeconomic impact; Plasma Medicine (PM) clearly can benefit healthcare for Canadians, as it already has in Europe.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2016-06429
Name nom
Wertheimer, Michael
Department département
Génie physique - Génie physique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Partie
1
Nb partie
5
Application title
Novel Thin Film Biomaterials for Tissue Engineering
Keyword
NSERC
Application summary
Deposition of thin films and etching via the use of ""cold"" (thermodynamically non-equilibrium) low-pressure (LP) plasmas achieved prominence in information technology since the 1960s. Those two processes and a third, surface modification of polymers, are now also being used in many other industries. Recently, there has been much progress in implementing atmospheric-pressure (AP) cold plasmas, mostly the dielectric barrier discharge (DBD) variety, for those three process categories. Beside direct use of LP and AP plasmas, it is also possible to carry out such processes by vacuum-ultraviolet (VUV, lambda = 200 nm) photo-chemistry, since commercial (plasma-based) VUV sources can efficiently convert electrical energy into short-wavelength photons. A potential advantage of (mono-energetic) photo- chemistry over (LP- and AP-) plasma is that the former may result in more targeted reactions, with higher yields of the desired products. Research in the applicant's laboratory of all types (LP, AP, VUV) above has over the years resulted in well over 400 refereed publications, in two dozen patents, and in much technology transfer to industry. He proposes innovative research focused on novel AP plasma techniques and on thin organic films deposited on suitable substrates for use in bio-technological (e.g. tissue engineering) applications. Such coatings must be rich in certain types of chemical functionalities, for example in primary amines (-NH2), carboxylic (COOR), hydroxyl (-OH), or thiol (-SH) groups, they must adhere strongly to various substrate materials, must resist ""aging"" in atmosphere and dissolution in aqueous (cell-culture) media, among other criteria. Finally, of course, they must first and foremost elicit the desired bio-response from the cell-type(s) being cultured. This latter aspect calls for close collaboration with specialists in the cell-biological and medical sciences that are being addressed in any given sub-project. During the past decade, the applicant's laboratory has developed networks of collaborations, mostly with senior researchers in the medical faculty of McGill and Montreal universities. In the recent past NSERC specifically included ""Plasma Applications"" among areas of Interdisciplinary Materials Research that possess particularly high potential for socioeconomic impact; Plasma Medicine (PM) clearly can benefit healthcare for Canadians, as it already has in Europe.